Phase IIb trial of twice-daily remogliflozin etabonate in treatment-naive patients with type 2 diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2016
At a glance
- Drugs Remogliflozin etabonate (Primary) ; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 23 Apr 2015 According to an Islet Sciences media release, data from this study were presented at the 50th International Liver Conference hosted by the European Association for the Study of Liver (EASL) 2015.
- 23 Apr 2015 Results published in an Islet Sciences Media Release.
- 14 Oct 2014 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History